BCX
BIOCELTIX
GPW
LISTED
source: current reports (ESPI/EBI) · incomplete data — not every contract is disclosed · 2 contracts in the database
DISCLOSED VALUE 12M
Sum of the value of contracts from the last 12 months where the company disclosed an amount; contracts with no disclosed value are excluded.
8.8 m PLN
2 of 2 contracts
SHARE OF REVENUE 12M
Disclosed contract value relative to the company's revenue; computed only when both figures are in PLN.
—
no revenue data in the database
LARGEST COUNTERPARTY
77.4%
Narodowe Centrum Badań i Rozwoju (NCBR)
LONGEST TERM
4 years
until 2029
No contracts in this category.
The registry is built from significant-contract announcements — none of this company's contracts carries the selected status.
Portfolio summary
Contracts
2
Active
2
Total value
8.8 m PLN
Average value
4.4 m PLN
Since
June 24, 2026
Where this data comes from
Contracts come from current reports (ESPI/EBI) — the company discloses only those exceeding its materiality threshold. The list is by definition incomplete.
Status — inferred from the event type and the term's end date, not a dedicated source field.
Share of revenue 12M — only when both the contracts' dominant currency and the company's reporting currency are PLN, with no currency conversion.